Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: E9AC46
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0008270 | zinc ion binding | 6 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0046914 | transition metal ion binding | 5 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 236 | 240 | PF00656 | 0.712 |
CLV_C14_Caspase3-7 | 36 | 40 | PF00656 | 0.503 |
CLV_NRD_NRD_1 | 267 | 269 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.414 |
CLV_PCSK_FUR_1 | 209 | 213 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.694 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.602 |
CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.423 |
CLV_PCSK_PC1ET2_1 | 211 | 213 | PF00082 | 0.694 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.646 |
CLV_PCSK_PC1ET2_1 | 232 | 234 | PF00082 | 0.602 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.368 |
DEG_SPOP_SBC_1 | 243 | 247 | PF00917 | 0.684 |
DOC_CDC14_PxL_1 | 173 | 181 | PF14671 | 0.493 |
DOC_MAPK_gen_1 | 182 | 190 | PF00069 | 0.449 |
DOC_MAPK_gen_1 | 52 | 59 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 182 | 190 | PF00069 | 0.510 |
DOC_MAPK_MEF2A_6 | 52 | 59 | PF00069 | 0.486 |
DOC_MAPK_NFAT4_5 | 52 | 60 | PF00069 | 0.488 |
DOC_PP2B_LxvP_1 | 133 | 136 | PF13499 | 0.623 |
DOC_PP4_FxxP_1 | 134 | 137 | PF00568 | 0.625 |
DOC_SPAK_OSR1_1 | 63 | 67 | PF12202 | 0.411 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.660 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.468 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.720 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.309 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.361 |
DOC_USP7_MATH_1 | 96 | 100 | PF00917 | 0.628 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.737 |
LIG_14-3-3_CanoR_1 | 275 | 281 | PF00244 | 0.553 |
LIG_14-3-3_CanoR_1 | 52 | 56 | PF00244 | 0.456 |
LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.556 |
LIG_FHA_1 | 239 | 245 | PF00498 | 0.741 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.533 |
LIG_FHA_2 | 212 | 218 | PF00498 | 0.651 |
LIG_FHA_2 | 232 | 238 | PF00498 | 0.671 |
LIG_LIR_Apic_2 | 132 | 137 | PF02991 | 0.611 |
LIG_LIR_Gen_1 | 122 | 133 | PF02991 | 0.611 |
LIG_LIR_Gen_1 | 170 | 180 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 39 | 47 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 54 | 59 | PF02991 | 0.396 |
LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.521 |
LIG_SH3_3 | 275 | 281 | PF00018 | 0.571 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.734 |
LIG_TRAF2_1 | 150 | 153 | PF00917 | 0.734 |
LIG_TRAF2_1 | 98 | 101 | PF00917 | 0.632 |
MOD_CK1_1 | 143 | 149 | PF00069 | 0.723 |
MOD_CK2_1 | 211 | 217 | PF00069 | 0.712 |
MOD_Cter_Amidation | 230 | 233 | PF01082 | 0.672 |
MOD_GlcNHglycan | 101 | 105 | PF01048 | 0.734 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.696 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.675 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.520 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.602 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.657 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.544 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.590 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.696 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.525 |
MOD_GSK3_1 | 227 | 234 | PF00069 | 0.753 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.662 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.474 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.624 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.771 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.503 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.592 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.520 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.356 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.689 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.632 |
MOD_PKA_1 | 211 | 217 | PF00069 | 0.746 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.662 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.649 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.451 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.491 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.356 |
MOD_Plk_2-3 | 126 | 132 | PF00069 | 0.535 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.482 |
MOD_Plk_4 | 38 | 44 | PF00069 | 0.356 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.496 |
MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.736 |
TRG_ER_diArg_1 | 181 | 184 | PF00400 | 0.404 |
TRG_ER_diArg_1 | 266 | 268 | PF00400 | 0.511 |
TRG_ER_diArg_1 | 51 | 53 | PF00400 | 0.405 |
TRG_ER_diArg_1 | 61 | 64 | PF00400 | 0.398 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P578 | Leptomonas seymouri | 45% | 74% |
A0A3R7NL08 | Trypanosoma rangeli | 31% | 91% |
A0A3S5H4V9 | Leishmania donovani | 85% | 79% |
A4HRH8 | Leishmania infantum | 89% | 100% |
E9AJE2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 76% |
V5BH18 | Trypanosoma cruzi | 30% | 77% |